Coronary intervention in thrombus-rich lesions: beyond stents and glycoprotein IIb/IIIa inhibitors

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomedical Engineering

Background:

• Percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) with high thrombus burden is associated with significant complications.
• Existing treatments like stents and GP IIb/IIIa antagonists have limitations in managing these complex cases.
• High thrombus burden increases the risk of distal microembolization, leading to myonecrosis and adverse clinical events.

Purpose of the Study:

• To review novel strategies for reducing thrombus burden in ACS patients.
• To evaluate the potential of new catheter-based systems and distal protection devices.
• To highlight the importance of procedural timing and patient selection in optimizing outcomes.

Main Methods:

• Review of current literature on thrombus burden management in ACS.
• Analysis of emerging technologies for thrombus removal and distal protection.
• Discussion of clinical implications and future directions.

Main Results:

• New catheter-based systems and distal protection devices show promise in reducing distal microembolization.
• These interventions may decrease the incidence of myonecrosis in high-risk ACS patients.
• Optimizing procedural timing and patient selection are crucial for improving outcomes.

Conclusions:

• Advanced thrombus burden reduction systems and distal protection devices offer potential improvements for ACS patients with high thrombus burden.
• Careful consideration of procedural timing and patient selection is essential for successful management and resource utilization.